Skip to main content
Clinical Pharmacology and Therapeutics logoLink to Clinical Pharmacology and Therapeutics
. 2011 Oct 12;90(6):894. doi: 10.1038/clpt.2011.152

CORRIGENDUM: Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

PMCID: PMC5225836

Clinical Pharmacology & Therapeutics (2012); 91 1, 894. doi:10.1038/clpt.2011.152

MV Relling, EE Gardner, WJ Sandborn, K Schmiegelow, C‐H Pui, SW Yee, CM Stein, M Carrillo, WE Evans and TE Klein

Clin. Pharmacol. Ther. 89, 387–391 (2011); doi:10.1038/clpt.2010.320

The authors note that Supplementary Table S1 appears incorrectly, in part. The table defines all the single‐nucleotide polymorphisms (SNPs) in thiopurine methyltransferase relative to the positive chromosomal strand, with the exception of rs1800462, which was left on the negative chromosomal strand. In the corrected table all SNPs are now listed relative to the same positive chromosomal strand. The corrected table appears below. This error does not affect the conclusions of the article.

Table S1.

Genotypes that constitute the * alleles for TPMT

graphic file with name CPT-90-894-g001.jpg


Articles from Clinical Pharmacology and Therapeutics are provided here courtesy of Wiley and American Society for Clinical Pharmacology and Therapeutics

RESOURCES